Condition (MeSH)
Eye Infections, Bacterial
ClinicalTrials.gov lists 88 trials for Eye Infections, Bacterial or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
9 of the 88 trials are tagged with Eye Infections, Bacterial itself; the rest are tagged with a narrower condition beneath it.
When did Eye Infections, Bacterial trials start? (26)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 7
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 2 |
| 2024 | 2 |
| 2023 | 1 |
| 2022 | 3 |
| 2021 | 4 |
| 2020 | 2 |
| 2019 | 4 |
| 2018 | 3 |
| 2017 | 3 |
Showing 10 of 26 earlier years.
No forecast is made for this condition: it averages 2.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Eye Infections, Bacterial trials in? (8)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 11 |
| Phase 1/2 | 1 |
| Phase 2 | 6 |
| Phase 2/3 | 3 |
| Phase 3 | 23 |
| Phase 4 | 27 |
| Not applicable | 12 |
| Observational | 5 |
How many Eye Infections, Bacterial trials are recruiting? (8)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 5 |
| Active, not recruiting | 1 |
| Completed | 63 |
| Suspended | 1 |
Showing 5 of 8 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Eye Infections, Bacterial trials? (9)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Alcon Research | 7 |
| Bausch & Lomb Incorporated | 7 |
| Laboratoires Thea | 7 |
| Laboratorios Sophia S.A de C.V. | 5 |
| Allergan | 3 |
Showing 5 of 9 sponsors.
Which drugs are being tested for Eye Infections, Bacterial? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Besifloxacin | 6 |
| Gatifloxacin | 4 |
| Ivermectin | 2 |
Interventions as named in the registry (12)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| 1% Azithromycin | 21 |
| C: moxifloxacin | 2 |
| Moxifloxacin hydrochloride ophthalmic solution 0.5% as base | 2 |
| Gatifloxacin 0.5% eye drops | 2 |
| Moxifloxacin Alternative Formulation (AF) Ophthalmic Solution 0.5% | 2 |
Showing 5 of 12 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Eye Infections, Bacterial trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Corneal perforation | 15 | 1 |
| Death | 12 | 1 |
| Loss of Consciousness | 2 | 1 |
| Anxiety | 1 | 1 |
| Cardiac failure congestive | 1 | 1 |
Showing 5 of 10 adverse events.
Which publications cover Eye Infections, Bacterial? (173)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Social Risk Factors Associated With Microbial Keratitis. | Cornea | 2026 | Yes |
| Endophthalmitis in Eyes Treated with the Port Delivery System with Ranibizumab: Summary of Cases during Clinical Trial Development. | Ophthalmology. Retina | 2025 | Yes |
| Factors Associated with Vision Outcomes in Microbial Keratitis: A Multisite Prospective Cohort Study. | Ophthalmology | 2025 | Yes |
| The Effect of Metagenomic Sequencing on Patient Clinical Outcomes for Intraocular Infections: A Multicenter Randomized Controlled Trial. | American journal of ophthalmology | 2025 | Yes |
| A comparison of antimicrobial regimen outcomes and antibiogram development in microbial keratitis: a prospective cohort study in Alexandria, Egypt. | Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2024 | Yes |
Showing 5 of 173 publications.
Sub-conditions in MeSH (3)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.